Clinical Study

Evaluation of Arterial Stiffness for Predicting Future Cardiovascular Events in Patients with ST Segment Elevation and Non-ST Segment Elevation Myocardial Infarction

Table 2

Clinical, laboratory, and hemodynamic characteristics of the study population.

Group 1
( )
Group 2
( )
P

Age NS
Sex
 Male11 (73%) 61 (77%) NS
 Female4 (27%)18 (23%)
BMI(kg/ ) NS
Weight (kg) NS
Height (m) NS
Diabetes mellitus7(47%)25 (32%) NS
Hypertension10 (67%) 36 (46%) NS
Hyperlipidemia9 (60%) 35 (44%) NS
Family history8 (53%) 22 (28%) NS
Smoker9 (60%) 38 (48%) NS
SBP (mmHg) NS
DBP (mmHg) NS
Heart rate (beat/min) 0.024
MAP (mmHg) NS
PP (mmHg) 0.012
PWV (m/s) <0.001
AIaortic(%) 0.033
AIbrachial(%) NS
RT (ms) <0.001
SAI [%] 0.035
DAI [%] 0.034
DRA 0.013
eGFR (mL/min/1.73  ) NS
HDL 0.002
EF (%) 0.002

BMI: body mass index; jugsy: jugulum-symphysis; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; PP: pulse pressure; eGFR: estimated glomerular filtration rate; HDL: high density lipoprotein; RT: return time; SAI: systolic area index; DAI: diastolic area index; DRA: diastolic reflection area; PWV: aortic pulse wave velocity; AI: augmentation index; SAI: systolic area index; DAI: diastolic area index; RT: return time; DRA: diastolic reflex area; NS: not significant; EF: ejection fraction; NS: not significant.